The Effect of Position on Pain, Bleeding, Hematoma and Vital Signs After Transfemoral Coronary Angiography

NCT ID: NCT06795308

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-03

Study Completion Date

2025-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, it was aimed to determine the effect of the special position given to the patient after transfemoral coronary angiography (supine position that varies depending on the angles) on pain, bleeding, hematoma and vital signs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since coronary angiography is an invasive procedure, the prevention of complications is critical for nursing care. As a result of this procedure, complications such as bleeding, local vascular problems such as hematoma, ecchymosis, pseudoaneurysm, pain and vasovagal reactions triggered by pain may occur. However, it is possible to minimize these complications with appropriate nursing approaches and care. By carefully monitoring patients before and after the procedure, nurses play an important role in reducing the risk of complications and ensuring patient safety.

The mobility of patients both in bed and in the room after coronary angiography may increase the rate of complications such as bleeding, pain and hematoma. For this reason, complete bed rest is traditionally recommended in addition to manual pressure application to stop bleeding after intervention in the femoral artery procedure. However, this approach may cause problems in terms of patient comfort and increases the workload of healthcare personnel. Sandbags are used to make prints in some clinics. However, while these bags cause pain and discomfort to patients due to lying still for a long time, they can also cause bleeding and hematoma due to slipping of the sandbag, and can be especially challenging for elderly patients. In this case, the methods that can be applied should be applied in a short time and easily. Positioning increases blood circulation and prevents contraction and spasm of the muscles. It is also easy and quick to apply. As a result of this method, the level of pain decreases. Positioning is effective in acute pain. It is not recommended to give a position without evaluating the general condition of the patient. An assessment of the overall situation is necessary to understand all of the patient's health needs and provide comprehensive care. This assessment helps to determine the patient's general health status, current symptoms, and needs. Positioning is also part of this assessment. The decrease in pain depending on the position reduces the patient's desire to move. This makes it easier to evaluate the patient in terms of the amount of bleeding and the risk of hematoma formation. In the literature, there are studies evaluating pain or hematoma after transfemoral coronary angiography by applying different methods. There is a study evaluating the effect of supine position on pain and hematoma. However, there are no studies evaluating the effect of four parameters including pain, bleeding, hematoma and vital signs. In order to eliminate this deficiency in the literature, it was aimed to evaluate the effect of supine position, which varies depending on the angles after transfemoral coronary angiography, on pain, bleeding amount, hematoma and vital signs in the patient. Four different hypothesis sets were established in the research. These; First Hypothesis Team H0: The position applied to transfemoral coronary angiography patients has no effect on pain.

H1: The position applied to transfemoral coronary angiography patients has an effect on pain.

Second Hypothesis Team H0: The position applied to transfemoral coronary angiography patients has no effect on bleeding.

H1: The position applied to transfemoral coronary angiography patients has an effect on bleeding.

Third Hypothesis Team H0: The position applied to transfemoral coronary angiography patients has no effect on hematoma formation.

H1: The position applied to transfemoral coronary angiography patients has an effect on hematoma formation.

Fourth Hypothesis Team H0: The position applied to transfemoral coronary angiography patients has no effect on vital signs.

H1: The position applied to transfemoral coronary angiography patients has an effect on vital signs Flow Process of the Study First Stage (Preparatory Stage): Appropriate environment arrangements will be made for the patients included in the intervention and control groups.

Second Phase (Implementation Phase): This phase will consist of ten steps. First step: In the first step of the application, patients who have undergone transfemoral coronary angiography in the Cardiology Service of Adana City Training and Research Hospital, who meet the research criteria and who are willing to participate in the research, will be given brief information about the research, and the "Informed Consent Form" will be filled out, and the written consent of the patients will be obtained.

Second step: Sample selection will be made in accordance with the inclusion, exclusion and exclusion criteria of the research, then randomization will be performed and two randomized groups will be formed. Patients will be informed about the purpose of the research and the research process, and the "Patient Introduction Form" will be filled, and the vital signs of the patients who will be in the intervention and control groups will be measured and recorded in the "Vital Signs Evaluation Form". According to the VAS, general body pain will be evaluated and recorded. Routine nursing care procedures will be applied to both groups. Patients will be followed up in the service until and after the transfemoral coronary angiography procedure.

Third step: In the transfemoral coronary angiography procedure; Before the angiography catheter is withdrawn after the trasnfemoral coronary angiography procedure of the patient in the intervention group and control group, the procedure area will be evaluated and recorded in terms of pain intensity, amount of bleeding and hematoma measure. The angiography catheter will be removed by the doctor.

Fourth step: At the 0th hour after transfemoral coronary angiography catheter is withdrawn; In the intervention group, the patient's bedhead 0 degree will be placed in the supine position with the treated leg straight and immobile, and in the control group, the patient's bedside 0 degree will be brought to the supine position with the treated leg straight and immobile, and a sandbag weighing 4 kg will be placed on the treated area. The patient will be evaluated for pain severity and vital signs will be measured and recorded.

Fifth step: At the 1st hour after the transfemoral coronary angiography catheter is removed; In the intervention group, the patient's bedhead 0 degree will be placed in the supine position with the treated leg straight and immobile, and in the control group, the patient's bedside 0 degree will be brought to the supine position with the treated leg straight and immobile, and a sandbag weighing 4 kg will be placed on the treated area.

Sixth step: Transfemoral coronary angiography at the 2nd hour after the catheter is removed; In the intervention group, the patient's bedside will be 15 degree, the treated leg will be placed in the supine position with straight and immobile, and in the control group, the patient's bedside will be 0 degree, the treated leg will be placed in the supine position with the treated leg straight and immobile, and a sandbag weighing 4 kg will be placed in the treated area. The patient will be evaluated in terms of pain severity, vital signs will be measured and recorded.

Seventh step: At the 3rd hour after the transfemoral coronary angiography catheter is withdrawn; In the intervention group, the patient's bedside will be 15 degree, the treated leg will be straight and immobile, and in the control group, the patient will be placed in a supine position with the patient's bedside 0 degree and the treated leg will be straight and immobile, and a sandbag weighing 4 kg will be placed on the treated area.

Eighth step: At the 4th hour after the transfemoral coronary angiography catheter is removed; In the intervention group, the patient's bedhead will be 30 degree, the treated leg will be placed in the supine position with the treated leg straight and immobile, and in the control group, the patient will be placed in the supine position with the patient's bedhead 0 degree and the treated leg straight and immobile, and a sandbag weighing 4 kg will be placed on the treated area. The patient will be evaluated in terms of pain severity, vital signs will be measured and recorded.

Ninth step: At the 5th hour after the transfemoral coronary angiography catheter is withdrawn; In the intervention group, the patient's bedside will be 45 degree, the treated leg will be placed in the supine position with the treated leg straight and immobile, and in the control group, the patient will be placed in the supine position with the patient's bedside 0 degree and the treated leg straight and immobile, and a sandbag weighing 4 kg will be placed in the treated area.

Tenth step: At the 6th hour after the transfemoral coronary angiography catheter is removed; The 4 kg sandbag of the patient in the intervention group and the control group will be removed. The patient's procedure area will be evaluated in terms of the amount of bleeding, hematoma size and pain severity, and vital signs will be measured and recorded.

Third Stage (Reporting Stage): At this stage, statistical analysis of the data obtained from the patients will be made and a research report will be written.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Disease Angiography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The first group will remain in the supine position for 6 hours after the Angiography procedure, and the treated leg will be kept straight and immobile. Patients will not move their legs during this period. A sandbag weighing approximately 4 kg will be placed over the catheter dressing for 6 hours to prevent bleeding and subcutaneous blood accumulation. For the first two hours, the patient will lie on his back and on a flat surface with his legs extended straight. During the remaining 4 hours, researchers will monitor the patient's bed head by raising it 15 degrees intermittently under the supervision of the doctor, and at the end of the 6th hour, the sandbag on the leg will be removed. Blood pressure, pulse rate, respiratory rate, body temperature, as well as pain level will be measured every two hours. In the second group, only the patient's bed head will remain flat and will not be elevated.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ENTERPRISE GROUP

The first group will remain in the supine position for 6 hours after the Angiography procedure, and the treated leg will be kept straight and immobile. Patients will not move their legs during this period. A sandbag weighing approximately 4 kg will be placed over the catheter dressing for 6 hours to prevent bleeding and subcutaneous blood accumulation. For the first two hours, the patient will lie on his back and on a flat surface with his legs extended straight. During the remaining 4 hours, investigators will monitor the patient's bed head by raising it 15 degrees intermittently under the supervision of the doctor, and at the end of the 6th hour, the sandbag on the leg will be removed. Blood pressure, pulse rate, respiratory rate, body temperature, as well as pain level will be measured every two hours.

Group Type ACTIVE_COMPARATOR

Bed Position and Head Elevation

Intervention Type OTHER

The first group will remain in the supine position for 6 hours after the Angiography procedure, and the treated leg will be kept straight and immobile. Patients will not move their legs during this period. A sandbag weighing approximately 4 kg will be placed over the catheter dressing for 6 hours to prevent bleeding and subcutaneous blood accumulation. For the first two hours, the patient will lie on his back and on a flat surface with his legs extended straight. During the remaining 4 hours, investigators will monitor the patient's bed head by raising it 15 degrees intermittently under the supervision of the doctor, and at the end of the 6th hour, the sandbag on the leg will be removed. Blood pressure, pulse rate, respiratory rate, body temperature, as well as pain level will be measured every two hours.

CONTROL GROUP

After the angiography procedure, the patient will remain in the supine position for 6 hours and the treated leg will remain straight and motionless. investigators will ask patients not to move their legs during this time. A sandbag weighing approximately 4 kg will be placed over the catheter dressing for 6 hours to prevent bleeding and subcutaneous blood accumulation. Patients will lie on their back and on a flat surface with their legs extended straight for 6 hours. At the end of the 6th hour, the sandbag on the leg is removed. Blood pressure, pulse rate, respiratory rate, body temperature, as well as pain level will be measured every 2 hours.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bed Position and Head Elevation

The first group will remain in the supine position for 6 hours after the Angiography procedure, and the treated leg will be kept straight and immobile. Patients will not move their legs during this period. A sandbag weighing approximately 4 kg will be placed over the catheter dressing for 6 hours to prevent bleeding and subcutaneous blood accumulation. For the first two hours, the patient will lie on his back and on a flat surface with his legs extended straight. During the remaining 4 hours, investigators will monitor the patient's bed head by raising it 15 degrees intermittently under the supervision of the doctor, and at the end of the 6th hour, the sandbag on the leg will be removed. Blood pressure, pulse rate, respiratory rate, body temperature, as well as pain level will be measured every two hours.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written and verbal permission was obtained to participate in the research.
* Able to read, write, speak and understand Turkish
* Those who are over 18 years old
* Planned transfemoral angiography was performed
* Having normal prothrombin time (PT) and international normalization ratio (INR)
* Being conscious, fully oriented and cooperative, and open to communication.
* Those whose general condition is good and comfortable (vital signs are within normal limits)
* Not using any sedative medication,
* Those who have not previously had widespread hemorrhage, large hematoma, or a pain sensation greater than 4.5 on the visual pain scale
* Patients with imaging, medical treatment, stents, balloons, stents and balloons as a result of the procedure
* Not having any psychiatric disease

Exclusion Criteria

* People with hemophilia or other coagulation defects
* Those with active hemorrhage
* Previously treated with streptokinase
* Using more than 2 anticoagulants or antiplatelets
* Those who have had back surgery/herniated disc,
* Having chronic waist, back or leg pain
* Using any of the complementary and integrated methods
* Do not use any analgesic before, during and after transfemoral angiography.
* Radial angiography procedure was performed
* Patients coming to the service with sandbags
* Those who had any health problems or lost their lives during the application process
* Those who cannot continue the research for any reason
* Patients who wish to leave the study with their own consent
Minimum Eligible Age

18 Hours

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mersin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mizgin Bakır

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Digdem LAFCI BAKAR, PhD

Role: PRINCIPAL_INVESTIGATOR

Mersin University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Adana City Training and Research Hospital

Adana, Yüreğir, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Digdem LAFCI BAKAR, PhD

Role: CONTACT

+905055803847

Mizgin BAKIR, Msc Student

Role: CONTACT

+905050156828

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Şerafettin DEMİR, professor

Role: primary

+903224559000 ext. +905050156828

References

Explore related publications, articles, or registry entries linked to this study.

Valiee S, Fathi M, Hadizade N, Roshani D, Mahmoodi P. Evaluation of feasibility and safety of changing body position after transfemoral angiography: A randomized clinical trial. J Vasc Nurs. 2016 Sep;34(3):106-15. doi: 10.1016/j.jvn.2016.05.001.

Reference Type RESULT
PMID: 27568318 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MERSİNU2024-TFCA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.